Lupus patients get access to experimental stem cell therapy
NCT ID NCT04907175
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 26 times
Summary
This study provides expanded access to an experimental stem cell treatment called HB-adMSCs for people with systemic lupus erythematosus (SLE). It is designed for individual patients who have their own stem cells banked at Hope Biosciences. The goal is to evaluate safety and how well the treatment controls the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEM LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.